Nano Letters · 2019 · 129 citations · 36 references
Either hypoxia in an acute ischemic stroke before thrombolysis or the oxygen-boost after thrombolysis cause a high level of free radicals, resulting in successive injuries to neurocytes. To treat an ischemic stroke, it is needed to scavenge free radicals, combining sequentially regulating hypoxia and oxygen-boost microenvironment. Here, we report an engineered nanosponge (Mn<sub>3</sub>O<sub>4</sub>@nanoerythrocyte-T7, MNET) that could remodel the microenvironment of a stroke by self-adapted oxygen regulating and free radical scavenging. With a long circulation time in blood due to the stealth effect of the erythrocyte and preferential accumulation in the infarct site by the assisting of T7 peptide, MNET exerts a distinct therapeutic effect in two stages of an ischemic stroke: (i) before thrombolysis, rescue neurocyte via rapid free radical scavenging and timely oxygen supply; (ii) after thrombolysis, suppress oxygen-boost via oxygen storage, as well as scavenge free radical to avoid reperfusion injury. MNET holds an attractive potential for ischemic stroke treatment via phased regulation of pathological microenvironment.
36
ROS scavenging Mn<sub>3</sub>O<sub>4</sub>nanozymes for<i>in vivo</i>anti-inflammation
Jia Yao, Yuan Cheng, Min Zhou et al. · Chemical Science · 2018 · 603 citations · Full text
Ceria Nanoparticles that can Protect against Ischemic Stroke
Chi Kyung Kim, Taeho Kim, In‐Young Choi et al. · Angewandte Chemie International Edition · 2012 · 584 citations